The research conducted by the Magli lab aims at understanding the molecular mechanisms at the basis of cell differentiation and stem cell maintenance, which play important roles during development and in tissue homeostasis.
The Jhun laboratory aims to identify the molecular mechanisms involved in the development of cardiovascular diseases. We are particularly interested in mitochondrial signaling pathways that control mitochondrial fission, fusion, and ion transport during physiological conditions, and how alterations in these processes influence mitochondrial and cellular function under pathological conditions.
Dan’s laboratory has a long-standing interest in regenerative and stem cell biology with a focus on the heart and skeletal muscle. In their studies of the heart and skeletal muscle, the Garry laboratory utilizes an array of technologies including gene disruption strategies, transgenesis, single cell genome analysis, gene editing (TALEN and CRISPR technologies), inducible ES/EB model systems, hiPSC technologies, FACS and other cellular, biochemical and molecular biological techniques.
Dr. Yannopoulos' lab is a pioneering and diverse group of collaborators that focuses on the management of cardiac arrest, the leading cause of mortality in the United States. Through a model of refractory cardiac arrest, we have managed to shift gears in cardiac arrest management through revolutionary approaches; such as, the impedance threshold device, extracorporeal cardiopulmonary membrane oxygenation (ECMO), and sodium nitroprusside.
Our main research interest involves investigating tumor heterogeneity and intercellular communication in a spectrum of invasive and aggressive solid tumor malignancies. Projects in our lab focus on investigating the biology of cancer cells as they relate to cancer cell invasion, progression, tumor recurrence, and chemotherapy resistance. We invite you to learn more about our work and our research team.
The Kamdar lab is investigating molecular mechanisms of advanced heart failure in neuromuscular cardiomyopathy. We utilize a bench-to-bedside approach using patient derived-human induced pluripotent stem cell cardiomyocyte model and human heart tissues with the ultimate goal of developing new therapies to benefit patients.
The focus of the O-Uchi laboratory is to understand the detailed mechanism underlying cardiac excitation and contraction/metabolism coupling by Ca2+ ion in the physiological and pathological conditions.
The van Berlo lab works to uncover the biological pathways that regulate cardiac regeneration. Over the past decade it has become clear that the heart contains a small fraction of cells, called stem cells or progenitor cells, which are undifferentiated and retain the capacity to become cardiomyocytes.
The Prins lab will work to define the molecular mechanisms that underlie right ventricular (RV) failure in pulmonary arterial hypertension (PAH). Although rare, PAH is a devastating disease with a median survival of only 5 years after diagnosis.
In my laboratory, we study the role of primary afferent neurons in the control of cardiovascular responses to exercise. We are interested in the basic mechanisms that drive the exercise pressor reflex (EPR) under normal, physiological conditions but we also have a great deal of interest in the control of the EPR in disease.
The Meyer lab is investigating the interaction of heart rate and calcium cycling in heart failure with preserved ejection fraction (HFpEF).
Obesity and cardiovascular disease are among the leading causes of morbidity and mortality worldwide. Our research focuses on the interplay between intermediary metabolism and these disease processes.
Our laboratory has a long-term interest in understanding the molecular mechanisms controlling lineage-specific differentiation of pluripotent stem cells (i.e. embryonic and adult reprogrammed stem cells), and applying this information to efficiently generate tissue-specific stem/progenitor cells endowed with in vivo regenerative potential.
The Dudley laboratory is a translational physiology laboratory that focuses on mechanisms, novel diagnostics, and innovative cures for arrhythmias and heart failure with preserved ejection fraction.
The Sachs Lab's goal is to identify molecular mechanisms of leukemia stem cell self-renewal in acute myeloid leukemia (AML). Self-renewal is a feature of leukemia stem cells that allow them to recapitulate leukemia and cause relapse.